NCT00801879View on ClinicalTrials.gov

Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Staphylococcus AureusHIV Infections
Interventions
DRUG

Mupirocin calcium ointment, 2%

0.25 g in each nostril twice daily for 5 days (given monthly for up to 8 months)

DRUG

Placebo ointment

Placebo ointment 0.25g in each nostril twice daily for 5 days (repeated monthly for up to 8 months)

Trial Locations (2)

10032

Columbia University, New York

10452

Project Samaritan Inc., The Bronx

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Columbia University

OTHER